The KYORIN Pharmaceutical Group aims to achieve sustainable growth and create corporate value in the medium to long term by promoting strategies through which the Group companies cooperate closely with each other and exert the maximum impact of the Group’s strength.

Value Creation Process

The KYORIN Pharmaceutical Group aims to contribute to the health of people around the world and enhance corporate value through the implementation of the value creation process.

The Kyorin Group strives to create value by addressing diversifying medical needs, while working to find solutions to social issues from an environmental, social, and governance (ESG) perspective, and sharing the results of those endeavors with all stakeholders. We believe the continuous implementation of this process for creating value will move us toward a sustainable society and achieve growth as a company, leading to enhanced corporate value.

* Click to enlarge